HDAC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.553200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.379000E-01
Normal-vs-Stage2
4.032800E-01
Normal-vs-Stage3
7.714800E-01
Normal-vs-Stage4
1.780970E-01
Stage1-vs-Stage2
7.248200E-01
Stage1-vs-Stage3
4.080400E-01
Stage1-vs-Stage4
1.773580E-01
Stage2-vs-Stage3
1.709430E-01
Stage2-vs-Stage4
5.650300E-02
Stage3-vs-Stage4
9.180500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.824000E-01
Normal-vs-AfricanAmerican
5.242600E-01
Normal-vs-Asian
2.934600E-01
Caucasian-vs-AfricanAmerican
8.848000E-01
Caucasian-vs-Asian
2.338800E-01
AfricanAmerican-vs-Asian
5.826000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.127600E-01
Normal-vs-Female
4.043600E-01
Male-vs-Female
4.528000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.059600E-01
Normal-vs-Age(41-60Yrs)
3.254000E-01
Normal-vs-Age(61-80Yrs)
5.145800E-01
Normal-vs-Age(81-100Yrs)
7.198400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.580200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.703000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.357000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.853600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.211800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.033800E-01
Normal-vs-Daily Drinker
4.612400E-01
Normal-vs-Weekly Drinker
9.045400E-01
Normal-vs-Occasional Drinker
1.791000E-01
Normal-vs-Social Drinker
6.385000E-01
Non Drinker-vs-Daily Drinker
6.754000E-01
Non Drinker-vs-Weekly Drinker
4.304400E-01
Non Drinker-vs-Occasional Drinker
7.802500E-02
Non Drinker-vs-Social Drinker
6.986800E-01
Daily Drinker-vs-Weekly Drinker
2.515800E-01
Daily Drinker-vs-Occasional Drinker
1.764790E-01
Daily Drinker-vs-Social Drinker
4.233800E-01
Weekly Drinker-vs-Occasional Drinker
2.569500E-02
Weekly Drinker-vs-Social Drinker
6.310400E-01
Occasional Drinker-vs-Social Drinker
3.782200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.382160E-01
Normal-vs-Grade 2
2.345700E-02
Normal-vs-Grade 3
3.649900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.260610E-01
Grade 1-vs-Grade 3
7.386400E-01
Grade 1-vs-Grade 4
1.382160E-01
Grade 2-vs-Grade 3
1.375420E-01
Grade 2-vs-Grade 4
2.345700E-02
Grade 3-vs-Grade 4
3.649900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.659000E-01
Normal-vs-NonDiabetic
4.297200E-01
Diabetic-vs-NonDiabetic
3.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.133000E-01
Normal-vs-NoPancreatitis
5.238000E-01
Pancreatitis-vs-NoPancreatitis
3.938000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.857800E-01
Normal-vs-N1
4.218400E-01
N0-vs-N1
9.316200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.102590E-01
Normal-vs-TP53-NonMutant
4.970600E-01
TP53-Mutant-vs-TP53-NonMutant
1.023690E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
